Research ArticleClinical Studies

An Institutional Audit of Maximum Heart Dose in Patients Treated With Palliative Radiotherapy for Non-small Cell Lung Cancer

CARSTEN NIEDER and KRISTIAN S. IMINGEN
In Vivo March 2021, 35 (2) 955-958; DOI: https://doi.org/10.21873/invivo.12336

Article Information

vol. 35 no. 2 955-958
DOI 
https://doi.org/10.21873/invivo.12336
PubMed 
33622888
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received November 9, 2020
  • Revision received December 7, 2020
  • Accepted December 8, 2020
  • Published online February 23, 2021.
Copyright & Usage 
Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. CARSTEN NIEDER1,2⇑ and
  2. KRISTIAN S. IMINGEN1,2
  1. 1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
  2. 2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway
  1. Correspondence to: Carsten Nieder, Department of Oncology and Palliative Medicine, Nordland Hospital, 8092 Bodø, Norway. Tel.: +47 75578449, Fax: +47 75534975, e-mail: carsten.nieder{at}nlsh.no
View Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
An Institutional Audit of Maximum Heart Dose in Patients Treated With Palliative Radiotherapy for Non-small Cell Lung Cancer
CARSTEN NIEDER, KRISTIAN S. IMINGEN
In Vivo Mar 2021, 35 (2) 955-958; DOI: 10.21873/invivo.12336
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Keywords